PI

Premier IncNASDAQ PINC Stock Report

Last reporting period 30 Jun, 2024

Updated 15 Nov, 2024

Last price

Market cap $B

1.963

Small

Exchange

XNAS - Nasdaq

PINC Stock Analysis

PI

Avoid

Based on Eyestock quantitative analysis, PINC`s fundamental data and valuation indicate an investment grade of Avoid at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

49/100

Low score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

-14.6 %

Overvalued

Market cap $B

1.963

Dividend yield

5.20 %

Shares outstanding

118.87 B

Premier, Inc. is a healthcare improvement company uniting an alliance of approximately 4,400 United States hospitals and health systems and approximately 225,000 other providers and organizations. It operates through two segments: Supply Chain Services and Performance Services. The Supply Chain Services segment includes the Company’s group purchasing organizations (GPO), supply chain co-management, purchased services, and direct sourcing activities. The Performance Services segment consists of three sub-brands, which include PINC AI, the Company’s technology and services platform; Contigo Health, the Company’s direct-to-employer business; and Remitra, the Company’s digital invoicing and payables business. It delivers technology-enabled platform that offers critical supply chain services, clinical, financial, operational and value-based care software as a service (SaaS) as well as clinical and enterprise analytics licenses, consulting services, and third-party administrator services

View Section: Eyestock Rating